Trial Profile
A Multicenter, Single-arm, Open II Phase Clinical Trial Evaluating the Efficacy of Chidamide Combined With Prednisone, Cyclophosphamide, Etoposide, and Methotrexate (PECM) in Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Jan 2021
Price :
$35
*
At a glance
- Drugs Tucidinostat (Primary) ; Cyclophosphamide; Etoposide; Methotrexate; Prednisone
- Indications T-cell lymphoma
- Focus Therapeutic Use
- 01 Nov 2017 New trial record